Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.

Saved in:
Bibliographic Details
Title: Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes.
Authors: Pilla SJ; General Internal Medicine, Johns Hopkins University, 2024 E. Monument St, Room 2-604A, Baltimore, MD, 21205, USA., Quan AQ; Johns Hopkins School of Medicine, 2202 E Fairmount Ave, Baltimore, MD, 21231, USA., Germain-Lee EL; Department of Pediatrics, Division of Pediatric Endocrinology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA.; Kennedy Krieger Institute, Broadway, Room 583, Baltimore, MD, 801 N, USA., Hellmann DB; Department of Medicine, Johns Hopkins University School of Medicine and Johns Hopkins, Bayview, Johns Hopkins Bayview Medical Center, Mason F. Lord Building, Center Tower, Room 322, 5200 Eastern Avenue, Baltimore, MD, 21224, USA., Mathioudakis NN; Endocrinology, Diabetes, and Metabolism, Johns Hopkins University, 1830 E. Monument Street, Suite 333, Baltimore, MD, 21287, USA. nmathio1@jhmi.edu.
Source: Current diabetes reports [Curr Diab Rep] 2016 Oct; Vol. 16 (10), pp. 91.
Publication Type: Journal Article; Review
Journal Info: Publisher: Current Science Country of Publication: United States NLM ID: 101093791 Publication Model: Print Cited Medium: Internet ISSN: 1539-0829 (Electronic) Linking ISSN: 15344827 NLM ISO Abbreviation: Curr Diab Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1539-0829
DOI:10.1007/s11892-016-0792-9